COMMUNIQUÉS West-GlobeNewswire

Elite Pharmaceuticals Receives FDA Approval for Generic Percocet® Tablets

03/07/2018 - 13:54

NORTHVALE, N.J., July 03, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, [...]

Auxly Provides Development Update on the FV Pharma Joint Venture

03/07/2018 - 13:00

VANCOUVER, British Columbia, July 03, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V:XLY) (" Auxly " or the " Company ") is pleased to provide the following construction development update on the joint [...]

Anavex Life Sciences Receives Approval To Initiate Phase 2b/3 Clinical Trial of ANAVEX®2-73 for the Treatment of Early Alzheimer’s Disease

03/07/2018 - 13:00

ANAVEX®2-73 Being Studied as Potential First Precision Medicine Biomarker-guided, Targeted Therapeutic in Alzheimer’s Disease Primary and Secondary Endpoints measuring Safety, and Cognitive and Functional Efficacy (ADAS [...]

iTeos Therapeutics Appoints Scott Chappel as Chief Scientific Officer

03/07/2018 - 13:00

iTeos Therapeutics Appoints Scott Chappel as Chief Scientific Officer Gosselies, Belgium – July 3, 2018 – iTeos Therapeutics SA, a biotechnology company developing novel cancer immunotherapies, today announced the [...]

Loop Industries Reports First Quarter of Fiscal 2019 Consolidated Results

03/07/2018 - 13:00

Announced activation of breakthrough Generation II technology Announced world’s first integrated waste to Loop™ PET resin manufacturing technology Company used $2.2 million for the quarter of cash in operating [...]

Milestone Scientific CompuFlo® Epidural System Selected to Objectively Measure the Integrity of a High Fidelity Epidural Simulator in Real Time; Research Article Published in Prominent Scientific Peer Reviewed Journal

03/07/2018 - 13:00

CompuFlo® Epidural System becoming accepted as best-in-class for measuring tissue density and needle location in real time LIVINGSTON, N.J., July 03, 2018 (GLOBE NEWSWIRE) -- Milestone Scientific Inc . (NYSE:MLSS), a [...]

The Ensign Group Acquires Idaho Skilled Nursing Facility

03/07/2018 - 13:00

MISSION VIEJO, Calif., July 03, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ:ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care and [...]

Akers Biosciences Further Extends Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test

03/07/2018 - 13:00

THOROFARE, N.J., July 03, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces agreements with six [...]

Six zones de l’expansion de 250 000 pieds carrés des serres de HEXO sont maintenant entièrement autorisées et opérationnelles

03/07/2018 - 12:30

GATINEAU, Québec, 03 juill. 2018 (GLOBE NEWSWIRE) -- La Société Hydropothecary (TSX:HEXO) (« HEXO » ou « la Société ») est heureuse d'annoncer que six des dix zones de son expansion de 250 000 pieds carrés sont [...]

Six Zones of HEXO’s 250,000 sq. ft. Greenhouse Expansion Now Fully Licensed and Operational

03/07/2018 - 12:30

GATINEAU, Quebec, July 03, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (“HEXO” or the “Company”) (TSX:HEXO) is pleased to announce that six of ten zones in its 250,000 sq. ft. greenhouse expansion are now [...]

Virbac : Declaration of the number of shares and voting rights as of June 2018, 30.

03/07/2018 - 12:00

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]

Virbac : Déclaration d'actions et de droits de vote au 30 Juin 2018

03/07/2018 - 12:00

DECLARATION D'ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d'actions composant le capital (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) [...]

Transactions in relation to share buyback program

03/07/2018 - 10:12

Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

ASLAN Pharmaceuticals Submits Clinical Trial Authorisation Application for First in Man Studies for ASLAN004

03/07/2018 - 10:01

SINGAPORE, July 03, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (ASLAN, 6497.TT) (NASDAQ:ASLN), a clinical-stage biopharmaceutical company based in Asia developing novel therapeutics for global markets, today [...]

FIT Biotech Oy: FIT Biotech webcasts the company half-year financial report on September 6th 2018, at 10.00 AM.

03/07/2018 - 09:01

FIT Biotech Oy Press Release July 3 rd 2018, 10.00 EET FIT Biotech webcasts the company half-year financial report on September 6 th 2018, at 10.00 AM. FIT Biotech's half-year financial report will be webcasted on [...]

Shire plc : Rule 2.9 Announcement

03/07/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 3 July 2018 Shire [...]

Motif Bio Announces Resignation of Robert Bertoldi from Board of Directors

03/07/2018 - 08:00

NEW YORK, July 03, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that Robert Bertoldi has [...]

FIT Biotech Oy: FIT Biotech webcasts the company half-year financial report on September 6th 2018, at 10.00 AM.

03/07/2018 - 07:31

FIT Biotech Oy Press Release July 3 rd 2018, 08.30 EET FIT Biotech webcasts the company half-year financial report on September 6 th 2018, at 10.00 AM. FIT Biotech's half-year financial report will be webcasted on [...]

NEOVACS ANNOUNCES THE RESULTS OF ITS PHASE IIB STUDY FOR IFNalpha KINOID IN THE TREATMENT OF LUPUS

03/07/2018 - 07:01

PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES THE RESULTS OF ITS PHASE IIB STUDY FOR IFN alpha KINOID IN THE TREATMENT OF LUPUS WHICH ALLOWS TO PROCEED WITH THE CLINICAL DEVELOPMENT INTO PHASE III THE [...]